カテゴリー： Market Monitor Global, 世界, 医療/バイオ

エナシデニブの世界市場見通し2023年-2029年

◆英語タイトル：Enasidenib Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5539）

◆商品コード：MMG23JU5539
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Enasidenib Market 調査レポートは次の情報を含め、グローバルにおけるのエナシデニブ市場規模と予測を収録しています。・世界のエナシデニブ市場：売上、2018年-2023年、2024年-2029年
・世界のエナシデニブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のエナシデニブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「50mg」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

エナシデニブのグローバル主要企業は、Celgene Corporationなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、エナシデニブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のエナシデニブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のエナシデニブ市場：タイプ別市場シェア、2022年
・50mg、100mg

世界のエナシデニブ市場：用途別、2018年-2023年、2024年-2029年
世界のエナシデニブ市場：用途別市場シェア、2022年
・病院、薬局

世界のエナシデニブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のエナシデニブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるエナシデニブのグローバル売上、2018年-2023年
・主要企業におけるエナシデニブのグローバル売上シェア、2022年
・主要企業におけるエナシデニブのグローバル販売量、2018年-2023年
・主要企業におけるエナシデニブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Celgene Corporation

*************************************************************

・調査・分析レポートの概要
エナシデニブ市場の定義
市場セグメント
世界のエナシデニブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のエナシデニブ市場規模
世界のエナシデニブ市場規模：2022年 VS 2029年
世界のエナシデニブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのエナシデニブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のエナシデニブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：50mg、100mg
エナシデニブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
エナシデニブの用途別グローバル売上・予測

・地域別市場分析
地域別エナシデニブ市場規模 2022年と2029年
地域別エナシデニブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Celgene Corporation
...

Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
This report aims to provide a comprehensive presentation of the global market for Enasidenib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enasidenib. This report contains market size and forecasts of Enasidenib in global, including the following market information:
Global Enasidenib Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Enasidenib Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Enasidenib companies in 2022 (%)
The global Enasidenib market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
50mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Enasidenib include Celgene Corporation. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enasidenib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enasidenib Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enasidenib Market Segment Percentages, by Type, 2022 (%)
50mg
100mg
Global Enasidenib Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enasidenib Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Enasidenib Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Enasidenib Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enasidenib revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Enasidenib revenues share in global market, 2022 (%)
Key companies Enasidenib sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Enasidenib sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celgene Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enasidenib, market overview.
Chapter 2: Global Enasidenib market size in revenue and volume.
Chapter 3: Detailed analysis of Enasidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enasidenib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Enasidenib capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Enasidenib Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Enasidenib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Enasidenib Overall Market Size
2.1 Global Enasidenib Market Size: 2022 VS 2029
2.2 Global Enasidenib Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Enasidenib Sales: 2018-2029
3 Company Landscape
3.1 Top Enasidenib Players in Global Market
3.2 Top Global Enasidenib Companies Ranked by Revenue
3.3 Global Enasidenib Revenue by Companies
3.4 Global Enasidenib Sales by Companies
3.5 Global Enasidenib Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Enasidenib Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Enasidenib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Enasidenib Players in Global Market
3.8.1 List of Global Tier 1 Enasidenib Companies
3.8.2 List of Global Tier 2 and Tier 3 Enasidenib Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Enasidenib Market Size Markets, 2022 & 2029
4.1.2 50mg
4.1.3 100mg
4.2 By Type – Global Enasidenib Revenue & Forecasts
4.2.1 By Type – Global Enasidenib Revenue, 2018-2023
4.2.2 By Type – Global Enasidenib Revenue, 2024-2029
4.2.3 By Type – Global Enasidenib Revenue Market Share, 2018-2029
4.3 By Type – Global Enasidenib Sales & Forecasts
4.3.1 By Type – Global Enasidenib Sales, 2018-2023
4.3.2 By Type – Global Enasidenib Sales, 2024-2029
4.3.3 By Type – Global Enasidenib Sales Market Share, 2018-2029
4.4 By Type – Global Enasidenib Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Enasidenib Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Enasidenib Revenue & Forecasts
5.2.1 By Application – Global Enasidenib Revenue, 2018-2023
5.2.2 By Application – Global Enasidenib Revenue, 2024-2029
5.2.3 By Application – Global Enasidenib Revenue Market Share, 2018-2029
5.3 By Application – Global Enasidenib Sales & Forecasts
5.3.1 By Application – Global Enasidenib Sales, 2018-2023
5.3.2 By Application – Global Enasidenib Sales, 2024-2029
5.3.3 By Application – Global Enasidenib Sales Market Share, 2018-2029
5.4 By Application – Global Enasidenib Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Enasidenib Market Size, 2022 & 2029
6.2 By Region – Global Enasidenib Revenue & Forecasts
6.2.1 By Region – Global Enasidenib Revenue, 2018-2023
6.2.2 By Region – Global Enasidenib Revenue, 2024-2029
6.2.3 By Region – Global Enasidenib Revenue Market Share, 2018-2029
6.3 By Region – Global Enasidenib Sales & Forecasts
6.3.1 By Region – Global Enasidenib Sales, 2018-2023
6.3.2 By Region – Global Enasidenib Sales, 2024-2029
6.3.3 By Region – Global Enasidenib Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Enasidenib Revenue, 2018-2029
6.4.2 By Country – North America Enasidenib Sales, 2018-2029
6.4.3 US Enasidenib Market Size, 2018-2029
6.4.4 Canada Enasidenib Market Size, 2018-2029
6.4.5 Mexico Enasidenib Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Enasidenib Revenue, 2018-2029
6.5.2 By Country – Europe Enasidenib Sales, 2018-2029
6.5.3 Germany Enasidenib Market Size, 2018-2029
6.5.4 France Enasidenib Market Size, 2018-2029
6.5.5 U.K. Enasidenib Market Size, 2018-2029
6.5.6 Italy Enasidenib Market Size, 2018-2029
6.5.7 Russia Enasidenib Market Size, 2018-2029
6.5.8 Nordic Countries Enasidenib Market Size, 2018-2029
6.5.9 Benelux Enasidenib Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Enasidenib Revenue, 2018-2029
6.6.2 By Region – Asia Enasidenib Sales, 2018-2029
6.6.3 China Enasidenib Market Size, 2018-2029
6.6.4 Japan Enasidenib Market Size, 2018-2029
6.6.5 South Korea Enasidenib Market Size, 2018-2029
6.6.6 Southeast Asia Enasidenib Market Size, 2018-2029
6.6.7 India Enasidenib Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Enasidenib Revenue, 2018-2029
6.7.2 By Country – South America Enasidenib Sales, 2018-2029
6.7.3 Brazil Enasidenib Market Size, 2018-2029
6.7.4 Argentina Enasidenib Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Enasidenib Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Enasidenib Sales, 2018-2029
6.8.3 Turkey Enasidenib Market Size, 2018-2029
6.8.4 Israel Enasidenib Market Size, 2018-2029
6.8.5 Saudi Arabia Enasidenib Market Size, 2018-2029
6.8.6 UAE Enasidenib Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celgene Corporation
7.1.1 Celgene Corporation Company Summary
7.1.2 Celgene Corporation Business Overview
7.1.3 Celgene Corporation Enasidenib Major Product Offerings
7.1.4 Celgene Corporation Enasidenib Sales and Revenue in Global (2018-2023)
7.1.5 Celgene Corporation Key News & Latest Developments
8 Global Enasidenib Production Capacity, Analysis
8.1 Global Enasidenib Production Capacity, 2018-2029
8.2 Enasidenib Production Capacity of Key Manufacturers in Global Market
8.3 Global Enasidenib Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Enasidenib Supply Chain Analysis
10.1 Enasidenib Industry Value Chain
10.2 Enasidenib Upstream Market
10.3 Enasidenib Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Enasidenib Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Enasidenib in Global Market
Table 2. Top Enasidenib Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Enasidenib Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Enasidenib Revenue Share by Companies, 2018-2023
Table 5. Global Enasidenib Sales by Companies, (K Units), 2018-2023
Table 6. Global Enasidenib Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Enasidenib Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Enasidenib Product Type
Table 9. List of Global Tier 1 Enasidenib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Enasidenib Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Enasidenib Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Enasidenib Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Enasidenib Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Enasidenib Sales (K Units), 2018-2023
Table 15. By Type - Global Enasidenib Sales (K Units), 2024-2029
Table 16. By Application – Global Enasidenib Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Enasidenib Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Enasidenib Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Enasidenib Sales (K Units), 2018-2023
Table 20. By Application - Global Enasidenib Sales (K Units), 2024-2029
Table 21. By Region – Global Enasidenib Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Enasidenib Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Enasidenib Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Enasidenib Sales (K Units), 2018-2023
Table 25. By Region - Global Enasidenib Sales (K Units), 2024-2029
Table 26. By Country - North America Enasidenib Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Enasidenib Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Enasidenib Sales, (K Units), 2018-2023
Table 29. By Country - North America Enasidenib Sales, (K Units), 2024-2029
Table 30. By Country - Europe Enasidenib Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Enasidenib Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Enasidenib Sales, (K Units), 2018-2023
Table 33. By Country - Europe Enasidenib Sales, (K Units), 2024-2029
Table 34. By Region - Asia Enasidenib Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Enasidenib Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Enasidenib Sales, (K Units), 2018-2023
Table 37. By Region - Asia Enasidenib Sales, (K Units), 2024-2029
Table 38. By Country - South America Enasidenib Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Enasidenib Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Enasidenib Sales, (K Units), 2018-2023
Table 41. By Country - South America Enasidenib Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Enasidenib Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Enasidenib Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Enasidenib Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Enasidenib Sales, (K Units), 2024-2029
Table 46. Celgene Corporation Company Summary
Table 47. Celgene Corporation Enasidenib Product Offerings
Table 48. Celgene Corporation Enasidenib Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Celgene Corporation Key News & Latest Developments
Table 50. Enasidenib Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Enasidenib Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Enasidenib Production by Region, 2018-2023 (K Units)
Table 53. Global Enasidenib Production by Region, 2024-2029 (K Units)
Table 54. Enasidenib Market Opportunities & Trends in Global Market
Table 55. Enasidenib Market Drivers in Global Market
Table 56. Enasidenib Market Restraints in Global Market
Table 57. Enasidenib Raw Materials
Table 58. Enasidenib Raw Materials Suppliers in Global Market
Table 59. Typical Enasidenib Downstream
Table 60. Enasidenib Downstream Clients in Global Market
Table 61. Enasidenib Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Enasidenib Segment by Type in 2022
Figure 2. Enasidenib Segment by Application in 2022
Figure 3. Global Enasidenib Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Enasidenib Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Enasidenib Revenue, 2018-2029 (US$, Mn)
Figure 7. Enasidenib Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Enasidenib Revenue in 2022
Figure 9. By Type - Global Enasidenib Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Enasidenib Revenue Market Share, 2018-2029
Figure 11. By Type - Global Enasidenib Sales Market Share, 2018-2029
Figure 12. By Type - Global Enasidenib Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Enasidenib Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Enasidenib Revenue Market Share, 2018-2029
Figure 15. By Application - Global Enasidenib Sales Market Share, 2018-2029
Figure 16. By Application - Global Enasidenib Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Enasidenib Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Enasidenib Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Enasidenib Revenue Market Share, 2018-2029
Figure 20. By Region - Global Enasidenib Sales Market Share, 2018-2029
Figure 21. By Country - North America Enasidenib Revenue Market Share, 2018-2029
Figure 22. By Country - North America Enasidenib Sales Market Share, 2018-2029
Figure 23. US Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Enasidenib Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Enasidenib Sales Market Share, 2018-2029
Figure 28. Germany Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 29. France Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Enasidenib Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Enasidenib Sales Market Share, 2018-2029
Figure 37. China Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 41. India Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Enasidenib Revenue Market Share, 2018-2029
Figure 43. By Country - South America Enasidenib Sales Market Share, 2018-2029
Figure 44. Brazil Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Enasidenib Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Enasidenib Sales Market Share, 2018-2029
Figure 48. Turkey Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Enasidenib Revenue, (US$, Mn), 2018-2029
Figure 52. Global Enasidenib Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Enasidenib by Region, 2022 VS 2029
Figure 54. Enasidenib Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ エナシデニブの世界市場見通し2023年-2029年(Enasidenib Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

エナシデニブの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp